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Omental masses are rarely seen in childhood. Omental mesenteric myxoid hamartoma is a very rare and
a new entity, ﬁrst described by Gonzalez-Crussi et al. The tumor originates from the omentum and
mesentery and presents as multiple nodules. It shares many morphologic features with inﬂammatory
myoﬁbroblastic tumor and therefore, may be considered as a variant of inﬂammatory myoﬁbroblastic
tumor. However, the clinical course and prognosis of this tumor is different. This rare and relatively new
pathology in childhood, mimicking malign tumor and sharing many histopathological features with
inﬂammatory myoﬁbroblastic tumor, is presented to emphasize that it is a clinically different entity in
terms of clinical picture and prognosis.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Omental masses are rarely seen in childhood. Omental mesen-
teric myxoid hamartoma (OMMH) is a very rare and a new entity,
ﬁrst described by Gonzalez-Crussi et al. [1]. It is the tumor of the
omentum and mesentery, presenting as multiple nodules. It is
histologically characterized by plump mesenchymal cells in myx-
oid, well-vascularized stroma [1,2]. OMMH shares many morpho-
logic features with inﬂammatory myoﬁbroblastic tumor (IMT) and
therefore, may be considered as a variant of IMT [3]. However, the
clinical course and prognosis of the tumor is different from that of
IMT. This rare and relatively new pathology in childhood,
mimicking malign tumor and sharing many histopathological fea-
tures with IMT, is presented to emphasize that it is a clinically
different entity from IMT in terms of clinical picture and prognosis.1. Case report
A 15-year-old girl admitted with a rapidly growing abdominal
mass in the last 3 months which completely ﬁlled the left upper
quadrant. There was no history of trauma, abdominal pain, nausea
or vomiting.BY-NC-ND license (http://
ospital, Department of Pedi-
656; fax: þ90 232 489 2315.
ncan).
Published by Elsevier Inc. All righPhysical examination revealed a ﬁrm, immobile solidmass ﬁlling
the left upper quadrant and epigastric region. Other examination
ﬁndings were normal. Routine laboratory ﬁndings and erythrocyte
sedimentation rate were also normal. Abdominal Doppler ultraso-
nography showed a 8  6 cm, vascularized, hipoechoic solid mass
with necrotic foci adjacent to the left kidney, the spleen and the tail
of pancreas and that the tumor was compressing these organs.
Abdominal magnetic resonance imaging revealed a solid mass of
93.7 87.7 mm in diameter in the coronal plane and 79 71mm in
the axial plane (Fig.1). The tumor was displacing the left kidney and
the spleen. Thoracal computed tomography was normal. The tumor
markers (CA 15-3, CA 19-9. CA 125, bHCG) were negative.
The patient was operated on with the prediagnosis of gastro-
intestinal stromal tumor or soft tissue sarcoma. At laparotomy, a
well-circumscribed tumor was found in the greater omentum. The
mass was rubbery, glistening and oedematous in nature and
8 10 cm in size. The reddish-yellow tumorwhichwasmainly solid
with some cystic elements showed regular modularity and
increased vascularization (Fig. 2). The tumorwas adherent to spleen
and stomach and it displaced them superiorly and laterally. How-
ever, there was no adhesion to adjacent organs and structures. The
mesenterium was normal. There was no obvious regional and
mesenteric lymph node enlargement or no intraperitoneal ﬂuid.
The mass was totally excised.
Histologically, the tumor consisted of a richly vascularized
myxoid stroma with plump mesenchymal cells (Fig. 3a). There was
no evidence of mitosis or necrosis. Immunohistochemically, tumorts reserved.
Fig. 1. Abdominal magnetic resonance imaging of the tumor compressing the left
kidney and the spleen.
Fig. 2. Intraoperative picture of the omental tumor.
A. S¸encan et al. / J Ped Surg Case Reports 2 (2014) 489e491490cells were positive for vimentin, negative for S-100, CD34, CD117,
smooth muscle actin and ALK (Fig. 3b). The histopathological ex-
amination revealed that the mass was omental mesenteric myxoid
hamartoma.
The postoperative course was uneventful. No early recurrence
was observed during one-year follow-up.2. Discussion
OMMH is a very rare tumor of gastrointestinal system. 10 cases
have been reported in the literature up to now [1e9]. It is a tumor
characterized with multiple omental and mesenteric nodules.
Although there are no large series about omental mesenteric
myxoid hamartoma in the literature, it is considered as a benign
tumor. Therefore, complete surgical resection is the only choice of
treatment. In the presented case, the tumor was totally and
completely resected with no complication.
Some authors report that the basic tissue patterns in IMT are
myxoid/vascular pattern, compact spindle cell pattern and hypo-
cellular ﬁbrous pattern. Tumors growing in a grape-like fashion in a
myxoid/vascular pattern are considered indicative of OMMH [4].
Especially these tumors may be multinodular and be localizedFig. 3. a: Plump mesenchymal cell proliferation in myxoid background (H&E, 20). b: Im
Vimentin (200).inside the abdomen like OMMH. One of the most important clinical
differences between OMMH and IMT is the localization of the tu-
mor. The other difference is the prognosis. IMTs are more
commonly localized in lungs, eye, brain and pericard. They are
rarely seen in the alimentary tract [10,11]. OMMT, however, origi-
nate from the gastrointestinal system. In the IMTcells, there may be
deceptive features of immaturity, high cellularity and aneuploidy.
Besides, associated chromosomal anomalies and recurrences may
be observed in IMT. No recurrence has been reported in OMMT up
to now and they are considered as benign tumors [1,2,4e9]. In this
presented case, no recurrence was observed in one-year follow-up.
Histologically, OMMH consists of plump basophilic cells con-
taining vesicular nuclei and prominent nucleoli in a richly vascu-
larized myxoid stroma. The myxoid matrix contains acid
mucopolysaccharides and the mitotic rate is low. Cellular foci
alternate with areas of collagenization. Rarely, vacuolated and
multinucleated cells are seen [1,2,12]. Mesenchymal cells are
immunoreactive for vimentin, smooth muscle actin and sometimes
for desmin and S-100 protein [4]. In the presented case, tumor cells
were positive for vimentin, negative for S-100, CD34, CD117,
smooth muscle actin and ALK.
Ultrastructural examination reveals immature mesenchymal
cells, ﬁbroblasts and vacuolated cells with dilated cisternae of
rough endoplasmic reticulum and dense structures resembling ly-
sosomes [1]. In some studies, the presence of clonal chrosomal
aberrations in the tumor has been reported to indicate that OMMH
is a neoplastic proliferation [2]. Gastrointestinal stromal tumors
(GISTs) originating from the omentum resemble omental mesen-
teric myxoid hamartoma histopathologically and immunohis-
tochemically. Microscopic examination dominantly reveals spindle
cell lesions and in less than 15%, myxoid and epitheloid tumors. It ismunohistochemistry demonstrates positive staining of these cells with antibodies to
A. S¸encan et al. / J Ped Surg Case Reports 2 (2014) 489e491 491important to distinguish OMMH from omental GISTs, because
complete surgical resection is curative in OMMH. However, further
medical treatments such as tyrosine kinase inhibitors are usually
required together with surgery in omental GISTs. Moreover, dif-
ferential diagnosis of inﬂammatorymalignant ﬁbrous histiocytoma,
leiomyosarcoma, solitary ﬁbrous tumor, cell-rich gastrointestinal
autonomic nerve tumor, myxoid sarcoma and myxoid liposarcoma
from OMMT should also be made [4,13].
3. Conclusion
Although OMMH is clinically a benign neoplasm, the clinical
picture and histological ﬁndings may mimic malign tumors of the
gastrointestinal system. The cellularity of the tumor and immature
appearance resemble malign tumors. The experience of both the
surgeon and the pathologist about this entity prevents unnecessary
postoperative adjuvant treatments. Omental myxoid hamartomas
must be considered in the differential diagnosis of abdominal
masses in childhood. Patients with OMMHmay not need long-term
follow-up and the parents of the patients can be informed about the
prognosis more clearly.
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